BRAF Inhibitor Encorafenib And Cetuximab Real Life Investigation of Next Generation CRC Treatment
- Status
- RECRUITING
- Phase
- N/A
Clinical Trials Related to Cetuximab
Related studies linked through entity extraction aliases.
Cetuximab Plus Paclitaxel as First Line for Recurrent and/or Metastatic SCCHN: Real World Data.
- Status
- COMPLETED
- Phase
- N/A
A Dose Escalation/Expansion Study of ERAS-601 in Patients With Advanced or Metastatic Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Cetuxibab to Reduce Circulating Tumor Cells in Early Stage NSCLC
- Status
- WITHDRAWN
- Phase
- PHASE2
Study of NKTR 255 in Combination With Cetuximab in Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
LY3214996 and Cetuximab Alone or in Combination With Abemaciclib for the Treatment of Unresectable or Metastatic Colorectal Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
A Study of Encorafenib Plus Cetuximab With or Without Chemotherapy in People With Previously Untreated Metastatic Colorectal Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Assessment of Efficacy and Safety of Monalizumab Plus Cetuximab Compared to Placebo Plus Cetuximab in Recurrent or Metastatic Head and Neck Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Early-Line Anti-EGFR Therapy to Facilitate Retreatment for Select Patients With mCRC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Avelumab Plus Cetuximab in Pre-treated RAS Wild Type Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
MoLiMoR - A Study With FOLFIRI-based First-line Therapy With or Without Intermittent Cetuximab
- Status
- COMPLETED
- Phase
- PHASE2
Conversion Therapy of RAS/BRAF Wild-Type Right-sided Colon Cancer Patients With Initially Unresectable Liver Metastases
- Status
- UNKNOWN
- Phase
- PHASE3
Study of Tepotinib Combined With Cetuximab in Participants With Left-Sided RAS/BRAF Wild Type Metastatic Colorectal Cancer (PERSPECTIVE)
- Status
- TERMINATED
- Phase
- PHASE2
AVELUMAB and CETUXIMAB and mFOLFOXIRI as Initial Therapy for Unresectable Metastatic Colorectal Cancer Patients
- Status
- COMPLETED
- Phase
- PHASE2
Cetuximab Re-challenge for Colorectal Cancer Liver Metastasis
- Status
- UNKNOWN
- Phase
- PHASE3
MEN1611 With Cetuximab in Metastatic Colorectal Cancer (C-PRECISE-01)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
TTX-080 HLA-G Antagonist in Subjects With Advanced Cancers
- Status
- RECRUITING
- Phase
- PHASE1
Efficacy and Safety Study of Combination of CPGJ602 and Chemotherapy, in First Line, With Wild KRAS/NRAS/BRAF in Metastatic Colorectal Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Safety and Preliminary Efficacy of SNK01 in Combination With Trastuzumab or Cetuximab in Subjects With Advanced HER2 or EGFR Cancers
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
A Study to Evaluate the Safety, Pharmacokinetics, and Activity of GDC-6036 Alone or in Combination in Participants With Advanced or Metastatic Solid Tumors With a KRAS G12C Mutation
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1